Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0761-2023

Drug recall · May 31, 2023

buPROPrion Hydrochloride Extended-Release Tablets recall

Why: Failed Dissolution Specifications; during stability testing

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceutical Industries Limited, Gujrat, India, NDC 47335-737-86

Lots / codes

Lots: HAC2240A, Exp 05/2023; HAC3162A, Exp 07/2023

Quantity
5,344 Bottles
Company
Sun Pharmaceutical Industries Inc, Princeton, NJ
Distribution
Nationwide in the U.S.A
Initiated
May 9, 2023 · Voluntary: Firm initiated
Classified
May 23, 2023
Reported
May 31, 2023
Ended
February 27, 2024
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.